Edition:
United States

Tenax Therapeutics Inc (TENX.OQ)

TENX.OQ on NASDAQ Stock Exchange Capital Market

1.33USD
10 Dec 2018
Change (% chg)

-- (--)
Prev Close
$1.33
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
53,870
52-wk High
$12.59
52-wk Low
$1.32

Chart for

About

Tenax Therapeutics, Inc. is a specialty pharmaceutical company. The Company is focused on identifying, developing and commercializing products for the critical care market. The Company's main product is levosimendan. Levosimendan is a calcium sensitizer developed for intravenous use in hospitalized patients with acutely... (more)

Overall

Beta: 1.92
Market Cap(Mil.): $14.39
Shares Outstanding(Mil.): 28.24
Dividend: --
Yield (%): --

Financials

  TENX.OQ Industry Sector
P/E (TTM): -- 92.25 33.63
EPS (TTM): -1.43 -- --
ROI: -114.61 0.28 15.02
ROE: -129.29 0.94 16.60

Earnings vs. Estimates